Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Human herpesvirus 6: a clinical update.

Danielle M Zerr¹

¹Children's Hospital and Regional Medical Center, Division of Infectious Diseases, Department of Pediatrics, University of Washington, Seattle, WA 98105, USA. zerr@u.washington.edu

Herpes : the Journal of the IHMF

|May 31, 2006

Summary

Human herpesvirus 6 (HHV-6) infects most children and establishes latency. Reactivation in immunocompromised individuals, particularly transplant recipients, can cause disease, with ongoing research into its epidemiology and clinical impact.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characteristics of Young Children Hospitalized With Acute Respiratory Failure From Infection With Respiratory Syncytial Virus, SARS-CoV-2, or Both, November 2023-March 2024.

Open forum infectious diseases·2026

Same author

Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026.

MMWR. Morbidity and mortality weekly report·2026

Same author

Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025.

MMWR. Morbidity and mortality weekly report·2025

Same author

Endogenous human herpesviruses 6A/B.

Journal of virology·2025

Same author

American Society for Transplantation and Cellular Therapy Series #9: Management of Human Herpesvirus 6B After Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T-Cell Therapy.

Transplantation and cellular therapy·2025

Same author

Comparison of mid-turbinate nasal and combined nasal-throat specimen types for detection of respiratory viruses in children.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2025

Area of Science:

Virology
Immunology
Infectious Diseases

Background:

Human herpesvirus 6 (HHV-6) is a ubiquitous virus belonging to the Roseolovirus genus.
Primary HHV-6 infection occurs in early childhood, leading to lifelong latency.
Reactivation of HHV-6 poses significant risks in immunocompromised hosts, especially transplant recipients.

Purpose of the Study:

To provide an update on recent findings concerning HHV-6 epidemiology and clinical manifestations.
To highlight new insights into HHV-6 primary infection, neurological disease, and its role in transplant settings.
To review current diagnostic approaches and antiviral treatment strategies for HHV-6.

Main Methods:

Review of recent scientific literature and clinical data on Human herpesvirus 6.
Analysis of epidemiological trends and clinical syndromes associated with HHV-6.
Evaluation of diagnostic methods and antiviral therapies for HHV-6 infections.

Main Results:

Significant advancements have been made in understanding HHV-6 subtypes A and B, particularly their differing epidemiology.
New data clarifies the impact of HHV-6 in primary infections, neurological complications, and post-transplant disease.
Current diagnostic tools and antiviral treatments for HHV-6 are being refined.

Conclusions:

Despite extensive research, many aspects of HHV-6 epidemiology and pathogenesis require further investigation.
Continued research is crucial for improving the management of HHV-6 infections, especially in vulnerable populations.
This update synthesizes current knowledge and identifies areas for future research in HHV-6.

Related Experiment Videos